BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chengcheng Yang, Haocheng Nan, Jiequn Ma, Lili Jiang, Qianqian Guo, Lili Han, Yamin Zhang, Kejun Nan, Hui Guo. High Skp2/Low p57Kip2 Expression is Associated with Poor Prognosis in Human Breast CarcinomaBreast Cancer: Basic and Clinical Research 2015; : BCBCR.S30101 doi: 10.4137/BCBCR.S30101
2
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
3
Pınar Atasoy, Erdal Yilmaz, Onder Bozdogan, Sebnem Ayva, Ertan Batislam. Expression profile and prognostic importance in prostate lesions of the reverse transcriptase component of human telomerase (hTERT) and of cyclin-dependent kinase inhibitor p57 (p57kip2a)International Urology and Nephrology 2009; 41(1): 55 doi: 10.1007/s11255-008-9399-7
4
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
5
Ruth Holm, Mette Førsund, Mai T. Nguyen, Jahn M. Nesland, Claes G. Trope, John Matthew Koomen. Expression of p15INK4b and p57KIP2 and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell CarcinomaPLoS ONE 2013; 8(4): e61273 doi: 10.1371/journal.pone.0061273
6
Yan Zhang, Xiaohong He, Xiaolin Chen, Hong Ma, Donghong Liu, Jinyun Luo, Zhimin Du, Yafei Jin, Yan Xiong, Jiangui He, Dianqiu Fang, Kuijian Wang, William E. Lawson, John C.K. Hui, Zhensheng Zheng, Guifu Wu. Enhanced External Counterpulsation Inhibits Intimal Hyperplasia by Modifying Shear Stress–Responsive Gene Expression in Hypercholesterolemic PigsCirculation 2007; 116(5): 526 doi: 10.1161/CIRCULATIONAHA.106.647248
7
Thomas P.J. Hofer, Marion Frankenberger, Karl J. Staples, Löms Ziegler-Heitbrock. Expression of p57-Kip2 in monocytes and macrophagesImmunobiology 2006; 211(6-8): 455 doi: 10.1016/j.imbio.2006.05.018
8
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
9
P Vlachos, B Joseph. The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamicsOncogene 2009; 28(47): 4175 doi: 10.1038/onc.2009.269
10
ABDU SELIM HAMID, JINRAN LI, YALI WANG, XIAODONG WU, HASSAN ABDELLAH AHMED ALI, ZHENWU DU, LIHUA BO, YUCHENG ZHANG, GUIZHEN ZHANG. Recombinant human decorin upregulates p57KIP2 expression in HepG2 hepatoma cell linesMolecular Medicine Reports 2013; 8(2): 511 doi: 10.3892/mmr.2013.1510
11
Yun Xiao, Xia Li, Yueying Yang, Yadong Wang, Shaoqi Rao. Cell cycle-dependent gene networks relevant to cancerProgress in Natural Science 2008; 18(8): 945 doi: 10.1016/j.pnsc.2008.03.003
12
Önder Bozdoğan, Pinar Atasoy, Ertan Batislam, M Murad Başar, Halil Başar. Significance of p57Kip2 Down-Regulation in Oncogenesis of Bladder Carcinoma: An Immunohistochemical StudyTumori Journal 2008; 94(4): 556 doi: 10.1177/030089160809400418
13
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrenceCritical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
14
F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, G A Calin, G L Grazi, C Giovannini, C M Croce, L Bolondi, M Negrini. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinomaOncogene 2008; 27(43): 5651 doi: 10.1038/onc.2008.178